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Using a 3-dimensional fibrin gel model system simu-
lating fibroplasia of wound repair, we investigated 
the interaction between keloid fibroblasts and fibrin 
matrix and compared it with that of normal fibro-
blasts. Normal skin fibroblasts caused fibrin gel 
degradation under serum-free conditions, whereas 
keloid fibroblasts did not cause microscopically detect-
able gel degradation. Fibrin gel degradation occurred 
through plasmin-mediated fibrinolysis, which was ini-
tiated by fibroblast-secreted urokinase plasminogen ac-
tivator (uPA). With regular and reverse fibrin overlay 
assays, normal fibroblasts exhibited high uP A but low 
plasminogen activator inhibitor-l (PAl-1) activities, 
and transforming growth factor-/31 prevented fibrino-
lysis of normal fibroblasts by upregulating PAI-1 while 
F ibrin, the most abundant extracellular matrix (EC M) protein during the initial tissue repair process, serves along with tlbronectin as a provisional matrix for cell migration and prolife ration (Grinne U, 1984; C lark, 1989). Experimental injection of fibrin into normal 
tissue causes rapid macrophage migration , capillary formation, and 
collagen deposition at the injection site, w hereas iJ~iectioll of 
collagen or fib roblasts produces no response (Knighton el nl, 1982). 
On [he other hand, defects in clot fo rmation or fib rin dissolution 
may result in delayed tissue repa ir and extensive scarring (reviewed 
in Dvorak ci nl, 1983). A causative ro le for fibrin in excess 
connective tissue formation is further illustrated in tumors, in which 
fibrin persists in the tUlnor stroma causing inflammation, repair, and 
excess deposition of connective tissue (Brown cl nl, 1988). T hese 
observations led Dvorak (1986) to characterize a tUlnor as "a 
wo und that never heals." 
Keloids, clinically defined as scars growing beyond the confines 
of original wounds, occur primarily in dark-skinned races and in 
gen e tically susceptible individuals (Ross 1968; Abergel aJ1d Uitto, 
1987; T uan cl nl, 1991.) . Fibroblasts iso lated f.·om keloid les ions 
exhibit fundame ntal difFerences that persist ;11 11;11'0. Keloid fibro-
blasts show initially high synthetic rates of collagen , e lastin, ti-
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downregulating uP A activities. In contrast, keloid fi-
broblasts exhibited an intrinsically high level of P AI-1 
and a low level of uP A. This change in the ratio of 
activator and inhibitor activities was attributed to al-
tered fibrin degradation by keloid fibroblasts. The 
PAI-1 increase was also demonstrated at the RNA level 
by Northern analysis. In terms of the pivotal role of the 
plasmin/plasminogen activator system in matrix re-
modeling, the elevated PAl-1level exhibited by keloid 
fibroblasts nlay have significant consequences not only 
in altered fibrin degradation, but also in subsequent 
repair steps that lead to keloids and fibrosis. Key /VOI'tis: 
./ibl-i1l gelflll'okillase type plasmitlOge1l a.ctivatOJ' (IIPA)ltl'alls-
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bronectin , and proteoglycans (Uitto Cf nl, 1985; Babu et nl, 1989, 
1992; Younai cf nl, 1994; Russell ct nl, 1995), which may be a result 
of their altered responses to m eta bolic modulators such as glucocor-
ticoids and growth f.,ctors (Russe ll ci nl, 1988, 1989; Babu ct nl, 
1992; Myles el nl, 1992; Younai cl nl, 1994). In this study, we used 
an ;11 1I;lm fibroplasia model, which consists of a 3_ditnensional 
fibrin ge l culture system with fibrobla sts seeded inside the fibrin gel 
(Tuan and Grinnell, 1989; Tuan cf nl. 1996), to study interactions 
between keloid fibroblasts and th e fibrin matrix and to determine 
whether the behavior of fibrob lasts of fibrotic origin is altered in 
remodeling of the provisional wound matrix. 
MATEIUALS AND METHODS 
Cclls l-hn11an normal , hypertrophi c scar, and keloid fibrob lasts were 
csw blishcd from the skin of donors using the explanr method (Freshncy, 
1983) . Cells were grown in Dulbecco 's m odified Eagle's medium (D.MEM) 
(GIllCO, Grand Island , NY) containing 1 % penicillin /s rreptom),cnl and 
.I 0'10, I"tal bovine serum (GlBCO). T he cnltures were incubated 111 a 
humidified incubator in an atmosphere of 5% CO2 and 95% air. Fibroblas.ts 
were harvested usin g 0.25% trypsin/O.05% ethylenediamine retraacetlc aCId 
\-lank, ' solu tion (GIBCO). Early passages (second to eighth) of cells we re 
lI sed ill the expcrinl cnts. 
Fibrinogcn Human fibrinogen (Kabi f'harl11acia. Franklin. OH) ~"as used 
in the preparation of fibrin ge ls. Briefly. fibrinogen was reconstituted 1Il 
d isti ll ed H 20, and the protein conccntration was determincd at opti ca l 
density (00) 280 nm. \l...econstituted fibrinogen was adjusted to 10 mg/ ml 
and stored at - 20°C. Plasminogen-deple ted fibrinogen was prcpared by 
passing reconstituted fibrinoge n through 1.6 X 12-cm columns of lyslI1e-
Sepharose 4B (Pharmacia Biotech, Uppsala . Sweden) (Deutsch and Mertz, 
1970). Fibrinogen was eluted with phosp hate-buffered sa line , and proteln-
con taining fractions were pooled and COl1ccntnlted b:lck to .t 0 1l1g!tnl usmg 
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Ccntricon-l0 concentrators (Amicoll Inc., Beverly, MA) . Control fibrin o-
gen was obtained by passing fibrinogen through 1.6 X 12-cm columns of 
underiva tizcd Sepharosc 4U. C lottabi li ty of fibrinogen or plasminogcn-
depletcd fibrinogen was dctermined by mixing 1-5 mg/ml fibrinogen with 
5 U of human thrombin (S igma, St. Louis, MO) and incubating for 30 min 
at 37°C. C lots were formcd and detach cd from test-tube wall s. Samples 
were ccntrifuged at 12,OOOg for '15 min. Concentrations of non polymerized 
fibrin ogen remai nin g in the so lution were 111caslIrcd tit OD 280 n111, and the 
percen tage of dattable fibrinogen was determilled . Fibrinogen used was 
greater than 95'% c1ottable. 
Preparation of Fibrin Gels The method for fibrin ge l preparation 
described previously (Tuan and Grinnell , 1989) was used , with a slight 
modifi cation. Bricfly, human skin fibroblasts (1 X 10" ce lls/ml) ill DMEM 
were addcd to a fibrinogcn solution at 30°C for a final fibrinogen 
concentration of 2.0 mg/ ml. Aliquots (0.1 ml) of the fibrinogen-fibroblast 
mixturc were placed in wells of 48-we ll tissue culture plates (Costar, 
Pleasanton , CAl with 1 U thrombin (Sigma) pcr sample. Each aliquot 
occupied an arca outlincd by an 8-mm-diamcter circular score in the well. 
O ne-ha lf millilitcr of medium was added to each ge l after the gel had 
polymcrized (37°C for 30 min). 
Plasminogen Activator Zymography T he proccdure used was that of 
Granelli-Piperno and Rcich (1978). Briefly , aliquots (30 ILl) of serum-fi'cc 
cu.lwrc media were subjected to electrophoresis on a 10% polyacrylamide 
gel containing 0.1% sodium dodecyl sulfate (S])S) . T he gel was washed for 
1 h at room temperaturc in 2.5'Yo Triton Xl 00 to rcmove S])S. Aftcr a brief 
rinse in distill ed watcr, the gel was placed on an indicator gc l la ycr (regular 
fibrin ove rl ay assay) that contained 1 .25'X, low- tcmperature gelling agarose, 
human plasminogen (50 ILg/ ml , Sigma), thrombin (0.05 U/ ml. Sigma) , and 
fibrin ogen (2 mg/ml) and was incubated in a humidiflcd chamber at 37°C . 
Plasminogen ac tivator (PA) acti vity appeared as c1car lysed bands in the 
opaque fibrin indica tor layer. T he indicator h, ycr was fixed and stained in 
0.5% alllido black in 70% methanol and 10% acetic acid for photography. 
To detect plasminogen activator inhibitor (PAl) , we washed SDS-
polyacrylamide gel electrophores is tcst samples in Triton X l 00 and placed 
them on a gel similar to the indi cator gel that containcd urokinase 
plasminogen activator (uPA) (2 U/ 1ll1. Sigma) (reve rse fIbrin overla y assay) . 
The gels were placed ill a humidified chamber at 37°C. The fibrin was lysed 
with the exception of the areas cO ll taining PAi s. 
Receptor-Bound PA Assay Ccll cultures exposed for 18 h to seru lll-fi'ce 
medium (DMEM) wcre washed twice with phosphate-buffe red saline and 
incubated for 3 min with glycine-HCI (50 111M) in 0.1 M NaCI, pH 3. at 22°C. 
After neutralization with 0.5 M Tris HCI, pH 7.8, the elua te was collected and 
ccll debris was removed by celltrifugation (Stopclli el ai, 1986). 
Northern Blots Standard Northern blot allal ysis was used to study ~A 
expressioll (Sam brook el (II . 1989). Briefly, RNA s;unples were extracted 
using g uanidiniulll thiocyanate and sc pilratcd by centrifuga tio n through 
cesium chloride. T ota l RNA (20 ILg/ lanc) was separated by electrophoresis, 
transfcrred to nylo ll fi lters, and bakcd at 80°C under vacuum for 2 h. After 
prehybridi zation. the radioactive- labeled DNA probes were hyb ridi zed to 
flitcrs for 20 h at 400C. washed , and visua lizcd by exposure to x-ray film at 
- 70°C. T he cDNA probes were labeled according to the method of 
Feinberg and Vogcls tein CI 984). All samples were standardized to the level 
of expression for L,-cubu lin in each cell strain. 
Hybridization Probes Specitic human cDNA probes for ul'A nucleo-
tides 623-H>.19, PAI-"I eDNA (fulllcngth) , and the full coding region of the 
uPA receptei- gene were used (Laug fI al. '1992). 
n.ESULTS 
Normal and Keloid Fibroblasts Exhibit Different Patterns of 
Fibrin Gel Degradation Three strains each of ke lo id and 
normal fibroblasts were incorporated into fibrin ge ls in w e ll s of a 
48-well plate and inc ubated with DMEM or DMEM supplemented 
with 10'1., serum (10ulr, feta l boviJle se rum) , transforming growth 
fac tor-/3, (TGF-/3,), platclet-derived g rowth fa ctor (PDGF), or 
basic fibrobla st-derived growth factor (FGF) (Fig 1). After 24 h of 
incubation, fibrin ge ls contain.ing normal fibroblasts in DME M o r 
DME M plus either PDGF or FGF di sin tegrated, whereas the others 
remain ed intact. In comparison with the intact ge ls, disintegrated 
ge ls showed large fIbrinolytic spots. In contrast, fibrin gels contain-
ing keloid fibroblasts remained intact regardless of the type of 
culture m edium added. The effcc ts of seve ral con centrations of 
serum , growth factors, o r combinations of g rowth factors were also 
tested; se rum con centrations of 1% and greater protected fibrin ge ls 
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Figure 1. Normal fIbroblasts eause fibrin gel degradation in 
DMEM or in DMEM plus PDGF or FGF, but keloid fibroblasts do 
not. Fibrin gels contain ing either normal (N 15. N66. N77) or keloid (K12 , 
1<50, 1(76) fibrob lasts were prepared in 48-well cell cu lturc plates (see 
M(licrinis nlld Melhods) and incubated with DMEM or DMEM plus J 0% fetal 
bovine se rU111 , TGF-f3 , (5 ng/Ill I) , PDGI' (5 Ilg/ ml) , or FGF (5 ng/ ml) . Gel. 
were incubated at 37"C for 24 h. Aftcr incubation, culture media were 
withdrawn from the gels and toluidine blue (0. 1 % in 3% paraformaldehyde-
phosphate-buffe red sa line) was used to stain the ge ls lor visualization. Small 
holes present in the gel indicatc gc l degradation. 
fi'om the di sintegration that occurre d in the presen ce of nonnal 
fibroblasts. TGF-/3 , (0 .1 to 10 ng/ml tested) at concentrations of 2 
ng/ ml and g rcater also prevented tibrin ge l degradation. The 
concentrations tested for POGF and FGF ranged fi"olll 0.1 ng/ml to 
10 ng/ ml; n either of these growth facto rs o r their combination 
sh owed an y e ffects (data not sh own). 
Normal and Keloid Fibroblasts Exhibit Different PA and 
PAl Profiles Fibrin gels without fibroblasts did not spontane-
ously di sin tegrate, indicating that fibroblasts were the cause of 
fibrin lysis. Additionally, fibrin gels prepared from fibrinogen 
deplete d of plasminogen by Iysine-Sepharose (Pharmacia Biotech) 
showed n o fibrin degradation, indicating that th e plasl11inogeu/ 
plasminogen ac tiva tor enzyme sys tem was in volved in the fibro-
blast-mediated fibrin d egradatio n. Serum-free culture supernatants 
and acidic ce ll e lutes (for receptor-bound PAl the refore were 
collec ted and analyzed for PA and PAl ac tiviti es, respectively, using 
regular and reverse fibrin overlay assays . Normal fIbroblastS 
sh owcd uPA ac tivity in the m o lecula r weight range of50-1 05 kDa 
(Fig 2; normal, DMEM). The hig h-m olecu lar-weight band was 
confirmed by immunoblot to be the uPA-PAI-1 complex (data not 
shown) . T he uPA activ ity present in thi s uPA-PAI complex (enzy-
matically inactive ill sitll) was due to artific ia l activation of PAl-
bo und uPA b y SDS during SOS-polyacrylamide ge l electrophoresis 
as part of the assay procedure (Granelli-Piperno and R e ich , 1978). 
T he uPA act ivi ty was drasti cally redu ced upon exposure to TGF-/3, 
(Fig 2 ; 110rmal, TGF-/3), but remained relatively unchan ged with 
PDGF treatment (Fig 2; 110rmal , PDGF) . 
In contrast, keloid fibroblasts sh owed very littl e or no secreted 
active ul'A in DMEM- or TGF-/3, -treated sampl es (Fig 2 ; keloid , 
OMEM and TGF-/3) . T he presen ce of the uPA-PAI-1 complex 
(approximate ly 105 kDa) in keloid samples indi cates that the uPA 
secreted b y keloid fibroblasts was mostly bound by PAl-I. A small 
amount o f uPA activity was present ill kelo id fibroblasts trea ted 
with PDGF (Fig 2; ke lo id, PDGF). 
Plasminogen activato r inhibitor was studied with reverse fib rin 
o ve rla ys. T h e results showed that the re was li ttle PA1-1 activity in 
the OMEM sample conditioned for 24 h by normal fibroblasts (Fig 
3 ; normal, OMEM). Both TGF- /3, and PO GF treatme nts increased 
PAI-l considerabl y (Fig 3 ; n orma l, TGF-/3 and PDGF). In contrast 
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Figure 2, Regular fibrin overlay assay demonstrates a difference in 
the activity of active uPA between normal and keloid fibroblasts. 
Culture media (OMEM, or OMEM pl us TGF-f3, 15 ng/ ml] or POGF 1.5 
ng/ml]) conditioned by normaJ (N IS) or keloid (K 12) fibro blasts were 
collected and concentr;lted IO-fold using Centricon-I 0 (Amicoll). Aliquots 
(30 !J.l) of each sample were separated by SDS-polyacrylamide gel electro-
phoresis and tested with the regular fibrin overlay assay . :l S desc ribed in 
NI(/Ier;(/ /s nlld Melli"ds. Purified ul'A (approx.imately 50 kDa) was included as 
contro l. The high-molecular-weighr proteins (approximately 105 kDa) 
present in both normal and keloid cell s arc uPA-I'AI-1 complex. The gel 
was stained with 0.5% amido black. 
ke loid fibro blasts showed much hig her PAI-1 (Fig 3; ke loid , 
DM.EM) than no rmal fibrob lasts. and this was increased further 
upon cell exposure to TGF-/3, (Fig 3; keloid , TGF-/3) . The level of 
PAI-1 , however, showed a sligh t decrease upo n exposu re to PDGF 
(Fig 3; keloid, PDGF) . Four add itio nal ke loid and two additio nal 
normal strains of fibrob lasts (including the othe r samples from Fig 
1) were tested and showed similar results (data no t shown). 
T h e receptor-bo und uPA on the ce ll surf.1ce was studied in acidic 
elu ates of fibrobl as ts. A high uPA acti vity WaS found in no rl1lal 
fibro blasts. Ke loid fibrob lasts, on the othe r hand , showed litde o r 
no uPA acti vity (Fig 4). Normal fibrobhlsts also showed a trace 
amo unt of uPA-PA I-1 compl ex (Fig 4; N1 5, approximately 105 
kDa), which was absent in ke loid ce lls. Togeth er the results showed 
that normal fibroblasts ex pressed high levels of secreted and cell 
surface-bound active uPA and low PAI-1 . [n contrast, keloid 
fibroblasts expressed hig h PAI-l acrivity w ith much less secreted 
and receptor-bound uPA. TGF-/3 , upregulated PAI- 1 but down-
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Figure 3. Reverse fibrin overlay assay demonstrates a difference in 
PAI- l activity between normal and keloid fibroblasts. C ul ture media 
(OMEM, or DMEM plus TGF- f3 , 15 ng/mlJ) or PDGF 15 ng/ Illll) condi-
tioned by normal (N15) or keloid (K I2) f,brob lasts were co ll ected. con-
centra ted, and examined as described in Fig 2. The fibrin agarosc inhibitor 
gel contained 2 U/ ml of uPA (rcverse fibrin overlay assay) . as described in 
M(/Ier;nls nlld M,'IIi"ds. The gel was stained with 0.5% amido black. 
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Figure 4, Normal fibroblasts show higher cell surface receptor-
bound uPA activity than keloid fibroblasts. Normal (N 'IS) and keloid 
(K I2) fibroblasts, plated ar a dell siry of 80 X 10' cells/cm' , were exposed 
to serLIm-fi·cc medium (DMEM) at 37°C [or 18 h. Subscqucn tly. culturcs 
were rin sed [\.vice w ith phosphatc-buU:-crcd srl linc nnd incub:ltcd for 3 m ill at 
22°C with glycine-HCl (50 mM) in 0. '1 M NaCI. pH 3. Aftcr ncutra li zation 
with 0.5 M Tris HCI. pH 7.5. rhc e1uat<! was co llectcd and concenrrated 
10-fold using Ccntricon-I 0 (Amicon). Aliquots (30 ILl) of thc eluates were 
cxanlillcd as o utlined i11 Fig 2 . T he gel was sraincd with O.S'XI amido black. 
regulated uPA <lc tlvltles in both no rmal and keloid fib roblasts. 
Furthe rm o re, the e ffects o f PDGF on PAl-1 and uPA seemed to be 
difFe rent be tween norm al and keloid fibroblas ts. 
Keloid Fibroblasts Exhibit Lower uPA and Higher PAI-1 
mRNA Than Normal Fibroblasts T he e"lJression of uPA, 
PAI-1 . and uPA recepto r from both n orm al and keloid fibroblasts 
wa s evalu ated at the mRNA level by Northern blots. Consistent 
with the enzym e studies, normal tibroblasts showed conside rably 
higher uPA mRNA but less PAI-l mRNA than kelo id fibroblasts 
(Fig 5). T he uPA receptor RNA was comparab le between ke l o~d 
and norm al fibrob las ts w h cn the tota l loading of RNA using tubulll1 
waS taken in to account (Fig 5) . Similar differences in the levels of 
uPA and PAI-1 were fo und in additio nal no rmal and kelOid 
fibrob lasts tested (data no t shown). 
DISCUSSION 
Using a fibrin gel culture m ode l that simula tes fibroplasia of woun d 
repair (Tuan and GI-inne ll. 1989), we found significant differen c~s 
between norm al and kelo id fibroblasts in remodel ing of the proVI-
sional fibrin wound matrix. Whereas fibr in ge l degrada tio n oc-
curred in serum-fi'ee culture conditi oned by nonn al fibrobla sts and 
was prevented by TGF-{3 and trea tment wi th seru m. kelo~d 
fibroblasts showed no fibri'n gel degradation. T his difFeren ce 111 
fibrin remodeling is attrib uted to the high intrinsic level of PAI-l 
and, simul taneously, to a low level of uPA in keloid fibroblasts, 
detec table at bo th thc enzym e and ml'tNA levels. 
Urokinase (uPA) and tissue-type PA arc tbe two .maj or elnymes 
activating plasmin , w hich degrades fibrin and hbronectU1 (for 
revie w see Dano c/ aI, 1985). Whereas the primary fun ction of 
t issue-type PA is thrombolys is, uPA has been shown to be impor-
tant in tissue remodeling, ce ll migration , and tumor invasion and 
m etastasis . [n thi s study, t1brin degradation was apparently caused 
by plasmin throug h plasminogen activa tion by fibrob last- secreted 
uPA, as plain t1brin ge ls o r ge ls prepared fro m fibrinogen deplered 
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Figure 5. Northern blot analysis of uPA, PAl-t, and uPA receptor 
expression in normal and keloid fibroblasts. Normal (N15) and k.eloid 
(1(12) fibroblast cultures at a density or80 X 10' ce lls/elll 2 were rinsed with 
phosphate-buffered sa line and extracted for R.NA with a procedure de-
scribed in Mlller;"'s "lid Methods. Twenty p,g of tornl RNA was londed 01'1 
each lane. Samples were standardized to the level of expression for 
a-tubulin in each cell stra in . 
of plasminogen by lysine-Sepharose (Deutsch and Mertz , 197() 
showed no fibl;n degradation. Both active and inactive uPA 
(inhibitor-bound high-molecular- weight complexes) were de-
tected in normal and keloid fIbroblasts (Figs 2, 3) . N evertheless, 
nonnal fibrobla sts exhibi ted much higher amounts of active uPA 
than did keloid fibroblasts in either the soluble o r receptor- bound 
fOlln (Fig 4). Receptor-bound uPA is responsible for loca lized 
pericellular proteolysis (Plow ci ai, 1986); therefore, fIbrin gel 
degradation by normal fibroblasts was attributed to the relatively 
high lIPA and low PAI-1 activities expressed by these ceUs. The 
inhibition of fibrin gel degradation i.n serum-containin g medi,l, 
however, was due to the presence of large amounts of the plasmin 
inhibitors a2-antiplasmin and a 2-maeroglobulin and of PAI-l 
(Collen cl aI, 1975; Straight and McKee, 1982) . The multifunc-
tional cytokine TGF-/3, (for review see Roberts and Sporns, 1990) 
was previously shown to regulate PA and PAl at bo th the protein 
and message levels (Laiho el ai, 1986; Wilson el ai, 1993) . As ill 
other ceU types (Laiho el nl, 1987; Kesk.i-Oja et ai, 1988), TGF-/3, 
drastica lly increased PAI-1 but decreased uPA enzyme levels. T hjs 
alte ration in the enzyme/in hibito r levels may be attributed diJ"ectiy 
to the effec t of TGF-/3, on fibrin gel degradation by normal 
fibroblasts . 
Ke loid fibro blasts not only exhibited a decreased amount of total 
uPA (either active, PAI-l bound and inactive, or cell surface 
receptor-bound), but also showed a very high level of PAI-1 (Fig 
3) . Similar results were obtained with all keloid fibrobla st strains 
used in the study. PAI-1 inhjbits l'A activ ities by fo rming a 1:1 
stoichiometric complex with uPA (K.tllithof, 1.988). PDGF, which 
increased PAI-1 without significantly affectin g uPA levels in normal 
fibroblasts (Figs 2, 3), did not prevent fibrin degradation by normal 
fibrobla sts, indicating that the increase of PAI-l in normal fibro-
blasts by POGF treatment may not be suftl cient to neutralize uPA 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
activities. On the other hand, keloid fibrobla sts showed all in crease 
in active uPA (Fig 2) bu t a slight decrease ill PAl-"l activity (Fig 3) 
when treated by PDGF. Nonetheless, this change in enzyme 
activities did not indu ce fIbrin degradation by keloid cells. T here 
are two possible explanatio ns. Fi rst, increased uPA may not be 
sufficient to induce fibrinol ys is; second , ke loid fibrobla sts may 
produce excess ECM molecules such as fibronectin or co llagen 
during cul tu re (Babu e/ ai, 1989; Younai el ai, 1994), which may 
stabilize the fibrin matrix against proteo lys is (Mirsh'lhi et nl, 1991 ). 
It was interesting to note the difference in PAI-l induction by 
POGF between normal and keloid fibroblasts. In this regard, it was 
shown previously that keloid fibrobl asts exhibited four to five times 
higher levels of PDGF-a receptors tb'1I1 did normal fibroblasts 
(Haisa el nf , 1994) . [t is not known whether this in crease in POGF-a 
receptors all"ects kelo id fibrobla st PAI-l expression in response to 
PDGF. 
The amounts of uPA and PAl-l mRNA from either normal or 
keloid fibroblasts were consistent with the enzyme activities (Fig 
5). The lack o f cell surface-bou nd uPA in kelo id fibroblasts was 
probably not du e to absence of ulJA receptor, as levels of uPA 
receptor were comparable between keloid and n onnal fibroblasts, 
taking into con sideration RNA loading fo r Northern analysis 
(standardized by tubulin) (Fig 5). 
PA/ plasmin 'lI1d metal!oproteinases are the twO main classes of 
enzymes implicated in the remodeling of ECM (for review see 
Alexander and Werb, 1989). Plasmin, in addition to its primary role 
in fibrin proteo lysis, has been implica ted as an enzym e activator for 
latent TGF-f3 (Lyons CI ai, 1988) and ccrt,lin procollagenases 
(M ignatti c( nl, 1986). In this regard, the intrinsic low level of uP A 
and high level of PAI-l expressed by keloid tlbroblasts Im1Y have 
signifi cant consequ ences in wound repair. For instance, the lack of 
fibrin matrix degradation as shown in the present study may lead to 
a prolonged repairin g process, and there fore excess connective 
tissue formation (reviewed in Dvorak cl ai, 1983; Dvorak, 1986). 
Furthermore, decreased pl<lsmin generation due to an altered 
uPA/ PAI-1 ratio may result in a lack of collagenase generation 
necessa ry for granulation tissue remodeling. T he recent observation 
ofLaug eI nl (1 993) is of interes t. T hey showed that overexpression 
of recombinant PAI-2 in HT108() sarcoma cells resulted in inhibi-
tion of receptor-bound ullA, with subsequent suppression ofmatrLx 
degradation and invasion because of the induction of a thick 
peritul110ral capsule ill I'i"". T hese findin gs were reproduced ill 
human melanoma cells overexpressing PAI-2, Witll subsequent 
supp ression of spontaneous metastasis (Mueller eI ai, 1995). Addi-
tionally, i" "Urn studies have clearly shown that interstitial colla-
genases degrade matl-ix collagens only after plasmin-dependent 
remova l of the surrounding glycoprote ins (Mo ntgomery el al. 
1993). T hus the lack of ECM g lycoprotein degradation. which 
prevents fibrobla st-derived collagenases frotTl rem odeling depos-
ited coll agen fll1rjls, may also contribute to keloid formation. 
U sing the ill )} iln) fibropl asia m odel, we ha ve del\1onstnl ted that 
keloid fibrobla sts behave diffe rently fi'om norma l fibrobl asts in 
fibrin gel degradation. The lack o f fibrin degrada tion by keloid 
fibroblasts was due to the intrinsic low uPA and high PAl- I 
activities expressed by the.lc cells. Beca use ECM rcorgallization and 
remodeling arc central processes in tissllc repair, the deranged 
events exhibited by ke loid fib roblasts in remodeling fIbrin matrices 
provide new illSights i.nto the pathogencsis o f ke loid forma tion . 
Hi t tlc/molJl/edge Ihe excel/elll lec/Illical assislatlcc of Vii II (/ Z ilallg olUI DOII;t! 511 /1 
I/Ilt/ olso 1I/OIIk Drs. SIISOIl D OlI'lIey. J"IIII R eilliJ"CII , Ifllli 7adclfsz ~Vcllis:: f or 
pr",;itlill.~ Ille slll~~ir.t/l skill olld SCar SIIIIIJlles. Tilis SII/d)' WIIS SI/ppor1ed b)' NotiOllal 
IIISlilllles ,1 H eo/III grallt A40409 10 T-L. T (((Id a grll lllle> HI. E.L. ji-Olll lite '<"il 
B'~~0I1 M" /lloriol Lllbomlories b)' Ihe T . ]. Mnttell F(If((ldnrie>lI./ilr Lel/ /w llio, Ccwerr 
atld AlDS Reselll"". 
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